- Seventeen US-based AI companies raised rounds of $100 million or more in the first seven weeks of 2026, with three crossing the $1 billion threshold: xAI ($20 billion), Anthropic ($30 billion), and SkildAI ($1.4 billion).
- Total funding across these 17 rounds exceeded $54 billion, driven by investors including SoftBank, Nvidia, Founders Fund, Sequoia, and Andreessen Horowitz.
- Seed-stage rounds reached unprecedented sizes, with humans& raising $480 million and Flapping Airplanes raising $180 million at the seed stage, challenging traditional venture funding conventions.
What Happened
By February 17, 2026, seventeen US-based AI companies had closed funding rounds of $100 million or more, according to a TechCrunch analysis by Rebecca Szkutak. Three companies raised rounds exceeding $1 billion. Fourteen others raised between $100 million and $1 billion. The pace set a record for AI funding concentration in such a short window, with all 17 rounds closing in just 49 days.
The largest rounds went to xAI at $20 billion (Series E), Anthropic at $30 billion (Series G, valuing the company at $380 billion), and SkildAI at $1.4 billion (Series C, valued at $14 billion). SkildAI, which builds AI models to power robots, attracted investment from SoftBank and Nvidia. Anthropic’s round included participation from Founders Fund, Coatue, and Nvidia.
Why It Matters
The concentration of capital signals that institutional investors are doubling down on AI infrastructure and applications despite questions about near-term revenue for many of these companies. Crunchbase separately reported that Q1 2026 shattered venture funding records globally, with AI driving much of the $300 billion total.
The scale of seed rounds is particularly striking and challenges long-standing venture capital conventions. AI research lab humans& raised $480 million at a $4.48 billion valuation at the seed stage. Flapping Airplanes raised $180 million at seed with a $1.5 billion valuation. Inferact closed a $150 million seed round backed by Andreessen Horowitz with an $800 million valuation. In previous venture cycles, rounds of this size were reserved for Series C or later. The shift suggests investors believe early positioning in AI is worth paying a premium that would have been considered irrational five years ago.
Technical Details
The 17 companies span diverse AI categories, reflecting the breadth of the current AI investment thesis. ElevenLabs ($500 million Series D, $11 billion valuation) and Deepgram ($130 million Series C, $1.3 billion valuation) focus on voice AI technology. Baseten ($300 million Series E, $5 billion valuation) provides AI inference infrastructure that developers use to deploy models in production. OpenEvidence ($250 million Series D, $12 billion valuation) builds medical AI systems. Arena ($150 million Series A, $1.7 billion valuation) operates an LLM evaluation platform. Runway ($315 million Series E, $5.3 billion valuation) develops media generation tools for video and image creation.
Other companies in the cohort include Decagon ($250 million Series D) for conversational AI, Goodfire ($150 million Series B) and Fundamental ($255 million Series A) for AI research, Simile ($100 million Series A, led by Index Ventures) for decision simulation, and PaleBlueDot AI ($150 million Series B) for AI compute infrastructure. The smallest round in the cohort, Simile’s $100 million, would have ranked among the largest AI rounds in any year prior to 2024.
Who’s Affected
The funding wave directly affects AI talent markets. Seventeen well-capitalized companies competing for researchers and engineers will continue driving compensation upward, particularly for machine learning engineers, infrastructure specialists, and AI safety researchers. Smaller AI startups face a harder fundraising environment, as institutional investors concentrate capital in fewer, larger bets rather than spreading it across many seed-stage companies.
Enterprise customers benefit from the competitive pressure. More funded companies building AI infrastructure, voice AI, and vertical applications means faster product development and downward pricing pressure across the sector. The diversity of funded categories also suggests that enterprise AI adoption will expand beyond chatbots and copilots into robotics, medical applications, and media generation.
What’s Next
The pace raises the question of whether AI funding has peaked or is still accelerating. xAI’s $20 billion round was followed by its acquisition by SpaceX, suggesting that even mega-rounds may lead to consolidation rather than independent growth. Whether the remaining 16 companies can generate revenue commensurate with their valuations, particularly the seed-stage companies valued above $1 billion with minimal or no revenue, will determine whether this moment represents rational investment or a repeat of previous venture cycles. The next major test comes when these companies report 2026 revenue figures against their combined $54 billion in fresh capital.
